Copyright: ©Author(s) 2026.
World J Orthop. Apr 18, 2026; 17(4): 116046
Published online Apr 18, 2026. doi: 10.5312/wjo.v17.i4.116046
Published online Apr 18, 2026. doi: 10.5312/wjo.v17.i4.116046
Figure 5 Effect of Xianling Gubao capsule on the mRNA expression of key bone metabolism factors in bone tissue of ovariectomized rats.
A: Expression level of osteoprotegerin; B: Expression level of receptor activator of nuclear factor-kappaB; C: Expression level of receptor activator of nuclear factor-kappaB ligand. Data are presented as the mean ± SD (n = 3). aP < 0.05 vs ovariectomy group; bP < 0.01 vs ovariectomy group; cP < 0.001 vs ovariectomy group; eP < 0.01 vs sham-operated group. Sham: Sham-operated; OVX: Ovariectomy; E2: Estradiol; XLGB-L: Xianling Gubao capsule-low; XLGB-M: Xianling Gubao capsule-middle; XLGB-H: Xianling Gubao capsule-high; OPG: Osteoprotegerin; RANK: Receptor activator of nuclear factor-kappaB; RANKL: Receptor activator of nuclear factor-kappaB ligand.
- Citation: Yu AX, Liang WH, Zhou YS, Li P, Ji JM, Zhang FW, Yu P, Liu J. Xianling Gubao capsule alleviates osteoporosis: Modulation of gut-bone axis and Wnt signaling. World J Orthop 2026; 17(4): 116046
- URL: https://www.wjgnet.com/2218-5836/full/v17/i4/116046.htm
- DOI: https://dx.doi.org/10.5312/wjo.v17.i4.116046